Esperion Therapeutics
ESPR
#8328
Rank
ยฃ0.12 B
Marketcap
ยฃ0.64
Share price
-10.32%
Change (1 day)
-58.75%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ0.10 Billion

According to Esperion Therapeutics's latest financial reports the company has ยฃ0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.11 B78.68%
2023-12-31ยฃ64.55 M-53.19%
2022-12-31ยฃ0.13 B-28.21%
2021-12-31ยฃ0.19 B-14.13%
2020-12-31ยฃ0.22 B46.12%
2019-12-31ยฃ0.15 B42.89%
2018-12-31ยฃ0.10 B-27.66%
2017-12-31ยฃ0.14 B-13.61%
2016-12-31ยฃ0.17 B19.72%
2015-12-31ยฃ0.14 B110.69%
2014-12-31ยฃ67.98 M86.7%
2013-12-31ยฃ36.41 M803.82%
2012-12-31ยฃ4.02 M298.56%
2011-12-31ยฃ1.01 M
2002-12-31ยฃ27.97 M-42.29%
2001-12-31ยฃ48.47 M3.02%
2000-12-31ยฃ47.05 M1187.77%
1999-12-31ยฃ3.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.45 B 321.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.85 B 685.92%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.30 B 14,045.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.73 B 6,125.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.18 B 72.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.17 B 64.38%๐Ÿ‡บ๐Ÿ‡ธ USA